Literature DB >> 1745358

Progressive depletion of fast alpha-actinin-positive muscle fibers in Duchenne muscular dystrophy.

C Minetti1, E Ricci, E Bonilla.   

Abstract

In normal human muscle, a monoclonal antibody against alpha-actinin recognizes an isoform that is only expressed in a population of fast fibers histochemically identified as type IIb or fast-twitch glycolytic. Immunohistochemical studies of muscle biopsies from patients with Duchenne muscular dystrophy (DMD) showed that the number of alpha-actinin-positive type IIb fibers was essentially normal in preclinical patients. Symptomatic patients between the ages of 3 and 5 years showed depletion of these fibers, which were not seen in patients older than 5 years. ATPase histochemistry showed that a few type IIb fibers were present in muscle from symptomatic DMD patients but lacked the fast isoform of alpha-actinin. The data suggest that type IIb fibers are affected early in DMD.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1745358     DOI: 10.1212/wnl.41.12.1977

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


  7 in total

1.  Accelerators, Brakes, and Gears of Actin Dynamics in Dendritic Spines.

Authors:  Crystal G Pontrello; Iryna M Ethell
Journal:  Open Neurosci J       Date:  2009-01-01

2.  Comparison of the myoplasmic calcium transient elicited by an action potential in intact fibres of mdx and normal mice.

Authors:  Stephen Hollingworth; Ulrike Zeiger; Stephen M Baylor
Journal:  J Physiol       Date:  2008-09-04       Impact factor: 5.182

Review 3.  Mechanisms of resistance to pathogenesis in muscular dystrophies.

Authors:  J P Infante; V A Huszagh
Journal:  Mol Cell Biochem       Date:  1999-05       Impact factor: 3.396

4.  Muscle fiber type-predominant promoter activity in lentiviral-mediated transgenic mouse.

Authors:  Tomohiro Suga; En Kimura; Yuka Morioka; Masahito Ikawa; Sheng Li; Katsuhisa Uchino; Yuji Uchida; Satoshi Yamashita; Yasushi Maeda; Jeffrey S Chamberlain; Makoto Uchino
Journal:  PLoS One       Date:  2011-03-18       Impact factor: 3.240

5.  Severe dystrophinopathy in a patient with congenital hypotonia.

Authors:  G Cordone; M Bado; G Morreale; M Pedemonte; C Minetti
Journal:  Childs Nerv Syst       Date:  1996-08       Impact factor: 1.475

6.  Accelerometric outcomes of motor function related to clinical evaluations and muscle involvement in dystrophic dogs.

Authors:  Mutsuki Kuraoka; Yuko Nitahara-Kasahara; Hisateru Tachimori; Naohiro Kato; Hiroyuki Shibasaki; Akihiko Shin; Yoshitsugu Aoki; En Kimura; Shin'ichi Takeda
Journal:  PLoS One       Date:  2018-12-11       Impact factor: 3.240

7.  Modeling Patient-Specific Muscular Dystrophy Phenotypes and Therapeutic Responses in Reprogrammed Myotubes Engineered on Micromolded Gelatin Hydrogels.

Authors:  Florian Barthélémy; Jeffrey W Santoso; Laura Rabichow; Rongcheng Jin; Isaiah Little; Stanley F Nelson; Megan L McCain; M Carrie Miceli
Journal:  Front Cell Dev Biol       Date:  2022-04-06
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.